Eterna Therapeutics
ERNA
#11154
Rank
A$4.14 M
Marketcap
A$2.45
Share price
0.62%
Change (1 day)
14.34%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -A$24.35 Million

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$21.19 Million, an increase over its 2024 earnings that were of -A$56.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$24.35 Million14.9%
2025 -A$21.19 Million-62.78%
2024 -A$56.93 Million84.63%
2023 -A$30.84 Million-16.24%
2022 -A$36.82 Million-80.08%
2021 -A$0.19 Billion1596.7%
2020 -A$10.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$11.70 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.29 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A$24 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-A$28.61 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-A$5.81 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$1.83 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$0.37 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA